OCT4 and SOX2 expression have been shown to be independent prognostic factors in cervical cancer, with OCT4 associated with poorly differentiated tumours and advanced stage disease [41], and SOX2 associated with poor overall survival and recurrence [42]. This evidence concerns the gene POU5F1 and cervical cancer.